Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser

Background and Objectives Rosacea results from sun‐induced hyper‐vascularity of exposed facial skin, often accompanied by acneiform papules and pustules. The pulsed‐dye laser has an unparalleled safety record and emits an ideal wavelength for treating the abnormal vessels that occur in rosacea patie...

Full description

Saved in:
Bibliographic Details
Published in:Lasers in surgery and medicine 2008-04, Vol.40 (4), p.233-239
Main Authors: Bernstein, Eric F., Kligman, Albert
Format: Article
Language:English
Subjects:
Adult
Aged
dye
Female
Humans
laser
Low-Level Light Therapy - instrumentation
Male
Middle Aged
Pain Measurement
pulse duration
pulsed
rosacea
Rosacea - surgery
spider vein
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Objectives Rosacea results from sun‐induced hyper‐vascularity of exposed facial skin, often accompanied by acneiform papules and pustules. The pulsed‐dye laser has an unparalleled safety record and emits an ideal wavelength for treating the abnormal vessels that occur in rosacea patients. In this study we investigate the ability of the long pulse‐duration pulsed‐dye laser to improve rosacea. Study Design/Materials and Methods Twenty subjects with rosacea were treated with the high‐energy, long pulse‐duration pulsed‐dye laser. An elliptical spot and long pulse‐duration was used to spot‐treat linear telangiectasias, while a circular spot and short pulse‐duration was used to treat the entire face. Improvement was determined by blinded evaluation of photographs and by the treating physician's subjective evaluation, before and 8 weeks following the final treatment. Results The average rosacea score as estimated by the treating physician decreased from 2.7±1.1 to 1.4+ 0.7 (mean+SD) on a 0–6 scale with 0 representing no rosacea and 6 representing the most severe rosacea (P
ISSN:0196-8092
1096-9101
DOI:10.1002/lsm.20621